| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 上海建发致新医疗科技集团股份有限公司(以下简称“建发致新”)创立于2010年,总部位于上海,属于建发集团成员企业。 作为全国性医疗器械供应链平台，建发致新主要从事医疗器械直销及分销业务,并为医院提供医用物资集约化运营(SPD运营管理&GPO集中供应)等服务,与100余家国内外知名医疗器械生产厂商建立并保持长期稳定的合作关系。 目前，建发致新在全国31个省、直辖市、自治区3000余家医疗机构提供上万种产品的直销服务,并通过建立辐射全国范围的分销网络,以医疗耗材和IVD诊断产品为切入点,经营美敦力、微创医疗贝克曼库尔特、迈瑞医疗等众多国内外知名企业产品,爱盖血管介入、外科产品、IVD诊断产品等领域。 | ||||||||||||||||||||||||
| Main Business | 主要从事医疗器械直销及分销业务，并为终端医院提供医用耗材集约化运营（SPD）服务。 | ||||||||||||||||||||||||
| Legal Representative | 余峰 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 陆启勇 | ||||||||||||||||||||||||
| Solicitors | 北京国枫律师事务所 | ||||||||||||||||||||||||
| Auditors | 容诚会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 021-60430840 | ||||||||||||||||||||||||
| Fax No | 021-60430840 | ||||||||||||||||||||||||
| Website | www.innostic.com/ | ||||||||||||||||||||||||
| jfzx@innostic.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 25/09/2025 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.640 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.960 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.462B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |